2017 American Transplant Congress

Tuesday, May 2, 2017

6:00pm-7:00pm

Personalized Tacrolimus (TAC) Dosing Using Genetic Variants in Caucasian Kidney Transplant (Tx) Recipients.

D. Margraf,¹ R. Brundage,¹ D. Schladt,² W. Guan,³ B. Wu,³ R. Remmel,⁴ C. Dorr,^2,7 D. Berglund,¹ R. Mannon,⁵ A. Matas,⁶ W. Oetting,¹ A. Israni,^2,7 P. Jacobson,¹ For the DeKAF Genomics Investigators.

Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Hall D1

6:00pm-7:00pm

Plasma Cell Hepatitis in Primary Sclerosing Cholangitis Patients: 15-Year Experience at a Transplant Center.

J. Putra,¹ T. Schiano,² M. Fiel.³

Poster Session D: Liver: Immunosuppression and Rejection  •  Hall D1

6:00pm-7:00pm

Population Pharmacokinetic Profiling of Tacrolimus in Renal Transplant Recipients (RTRs) Taking Diltiazem.

P. Trevillian,^1,2,3 M. Heer,^1,2 S. Ainsworth,¹ A. Hibberd.^1,2,3

Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Hall D1

6:00pm-7:00pm

Post-Transplant Graft Function Is Associated with Major Cardiovascular Events in Kidney Transplant Recipients: A Multicenter Cohort Study.

J. Park,¹ Y. Kim,² S. Yang,³ S. Park,² S.-K. Park,⁴ D. Han,⁵ Y. Kim,² Y. Kim,⁵ J. Lee.⁶

Poster Session D: Kidney: Cardiovascular and Metabolic  •  Hall D1

6:00pm-7:00pm

Potential Living Kidney Donors (LKD) Concerns About Opting Out and Preferences for an 'Alibi'.

K. Yu,¹ C. Thiessen,¹ S. Li,¹ D. Dobosz,¹ J. Gannon,¹ K. Kennedy,² D. Gray,³ A. Mussell,³ P. Reese,³ S. Kulkarni,¹ E. Gordon.²

Poster Session D: Non-Organ Specific: Economics, Public Policy, Allocation, Ethics  •  Hall D1

6:00pm-7:00pm

PPAR-γ Agonist Attenuates Hepatic Ischemia-Reperfusion Injury in a Mouse Model by Regulating Kupffer Cell Polarization.

I. Linares, K. Farrokhi, J. Echeverri, M. Kaths, D. Kollman, M. Hamar, P. Urbanellis, S. Ganesh, O. Adeyi, P. Yip, N. Selzner, M. Selzner.

Poster Session D: Ischemic Injury and Organ Preservation Session III  •  Hall D1

6:00pm-7:00pm

Practice Patterns in the Treatment and Monitoring of Acute Cell-Mediated Kidney Graft Rejection in Canada.

J. Leblanc,¹ P. Subrt,² M. Paré,³ D. Hartell,⁴ L. Sénécal,⁵ T. Blydt-Hansen,⁶ H. Cardinal.¹

Poster Session D: Kidney: Acute Cellular Rejection  •  Hall D1

6:00pm-7:00pm

Pre Transplant Donor Specific Antibodies and Clinical Outcomes in Kidney Transplant Recipient on Steroid Free Maintenance Immunosupression Regimen.

O. Adebiyi,¹ A. Sharfuddin,² M. Yaqub,¹ S. Hussain,¹ D. Mishler,¹ A. Sharfuddin,¹ W. Goggins,¹ T. Taber.¹

Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Hall D1

6:00pm-7:00pm

Pre-Kidney Transplant Lower Extremity Impairment and Post-Transplant Mortality.

A. Nastasi,^1,2 M. McAdams-DeMarco,^1,2 J. Schrack,¹ H. Ying,² C. Haugen,² M. González Fernández,³ D. Segev.^1,2

Poster Session D: Non-Organ Specific: Economics, Public Policy, Allocation, Ethics  •  Hall D1

6:00pm-7:00pm

Pre-OLT CKD-3 Increases Post-OLT ESRD and AKI Impacts Early Post-OLT Survival.

G. Faddoul, L. Liriano-Ward, P. Chang, Y. Azzi, K. Chauhan, G. Nadkarni, V. Nair, R. Kent, S. Lerner, S. Coca, P. Heeger, S. Florman, S. Thomas, M. Menon.

Poster Session D: Liver - Kidney Issues in Liver Transplantation  •  Hall D1